Jushi Holdings (JUSHF) Accumulated Expenses (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Accumulated Expenses of $25.9 million for Q2 2026, down 3.55% year-over-year from $26.9 million in Q2 2025, and down 4.19% quarter-over-quarter from $27.0 million in Q1 2026.
Jushi Holdings (JUSHF) Accumulated Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Accumulated Expenses for 6 consecutive years, with $25.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accumulated Expenses fell 3.55% year-over-year to $25.9 million; the TTM figure through Jun 2026 stood at $25.9 million (down 3.55% YoY), while the FY2025 annual figure was $25.5 million, down 22.13% from the prior year.
- Accumulated Expenses fell to $25.9 million in Q2 2026 per JUSHF's latest filing, from $27.0 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $49.9 million in Q2 2023 and bottomed at $24.9 million in Q1 2025.
- Historically, Accumulated Expenses has averaged $36.9 million across 5 years, with a median of $35.9 million in 2024.
- Annual changes were most pronounced in 2024 — Accumulated Expenses grew 10.67% — and 2025, when it slumped 42.27%.
- Jushi Holdings' Accumulated Expenses stood at $46.3 million in 2022, then dropped by 4.88% to $44.1 million in 2023, then slipped by 25.6% to $32.8 million in 2024, then retreated by 22.13% to $25.5 million in 2025, then increased by 1.46% to $25.9 million in 2026.
- Business Quant data shows JUSHF's Accumulated Expenses at $25.9 million in Q2 2026, $27.0 million in Q1 2026, and $25.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.91 Mn |
| Mar 31, 2026 | 27.04 Mn |
| Dec 31, 2025 | 25.53 Mn |
| Sep 30, 2025 | 29.03 Mn |
| Jun 30, 2025 | 26.86 Mn |
| Mar 31, 2025 | 24.91 Mn |
| Dec 31, 2024 | 32.79 Mn |
| Sep 30, 2024 | 35.77 Mn |
| Jun 30, 2024 | 35.88 Mn |
| Mar 31, 2024 | 43.15 Mn |
| Dec 31, 2023 | 44.07 Mn |
| Sep 30, 2023 | 47.41 Mn |
| Jun 30, 2023 | 49.86 Mn |
| Mar 31, 2023 | 38.99 Mn |
| Dec 31, 2022 | 46.33 Mn |
| Sep 30, 2022 | 44.10 Mn |
| Jun 30, 2022 | 49.17 Mn |
| Dec 31, 2021 | 47.97 Mn |